SCHEMBL20760320

SCHEMBL20760320

c1ccc2c(c1)NC(c1ccc3c(c1)OCCN3)O2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
HSD17B10 Q99714 4/20 0.42
KDM4E B2RXH2 4/20 0.42
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
NISCH Q9Y2I1 1/20 0.35
NPC1 O15118 3/20 0.34
RAB9A P51151 2/20 0.34
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
AURKA O14965 1/20 0.33
RAD52 P43351 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LMNA P02545 2/20 0.33
HPGD P15428 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19062105 0.78 MAPT (0.47) ALDH1A1KDM4EMAPTNISCHNPC1
SCHEMBL22137418 0.77 KDM4E (0.39) ALDH1A1HSD17B10KDM4EGAAMAPT
SCHEMBL31149 0.75 KMT2A (0.49) ALDH1A1HSD17B10KDM4EGAAMAPT
SCHEMBL88894 0.74 GAA (0.55) ALDH1A1HSD17B10GAAMAPTNISCH
SCHEMBL871099 0.74 GAA (0.55) ALDH1A1HSD17B10GAAMAPTNISCH
SCHEMBL56313 0.74 GAA (0.55) ALDH1A1HSD17B10GAAMAPTNISCH
SCHEMBL8942627 0.74 GAA (0.55) ALDH1A1HSD17B10GAAMAPTNISCH
Hydrochloric Acid SCHEMBL27373511 0.72 GAA (0.53) ALDH1A1HSD17B10GAAMAPTNISCH
SCHEMBL20953362 0.71 MAPT (0.38) ALDH1A1KDM4EMAPTNISCHNPC1
SCHEMBL20953374 0.71 MAPT (0.38) ALDH1A1KDM4EMAPTNISCHNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200255421-A1 TETRAHYDROPROTOBERBERINE COMPOUND, PREPARATION METHOD THEREFOR AND USES THEREOF, AND PHARMACEUTICAL COMPOSITION TOPHARMAN SHANGHAI CO., LTD. (CN) 2020-08-13 US disclosed
EP-3670511-A1 TETRAHYDROPROTOBERBERINE COMPOUND, PREPARATION METHOD THEREFOR AND USES THEREOF, AND PHARMACEUTICAL COMPOSITION Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2020-06-24 EP disclosed
WO-2019034031-A1 TETRAHYDROPROTOBERBERINE COMPOUND, PREPARATION METHOD THEREFOR AND USES THEREOF, AND PHARMACEUTICAL COMPOSITION 中国科学院上海药物研究所 2019-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255421-A1 TETRAHYDROPROTOBERBERINE COMPOUND, PREPARATION METHOD THEREFOR AND USES THEREOF, AND PHARMACEUTICAL COMPOSITION NOTUM, BHMT, CYP4F11 ALDH1A1 446/4885HSD17B10 490/4885KDM4E 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.